Morning Headlines 11/15/18
RenalytixAI raises $29 million in an IPO that will be used to fund the launch of AI-enabled applications for the early detection of kidney disease and transplant management.
Dartmouth-Hitchcock Health teams with Philips on Tele-ICU program
Dartmouth-Hitchcock Health (NH) will use technology from Philips to develop a tele-ICU program, initially focusing on medical, surgical, and neurology ICUs.
Allscripts rebrands its Payer & Life Sciences Division to Veradigm, offering clinical workflow, research, and analytics software and services to providers, payers, and health IT and life sciences companies.
FDA guidance regarding SaMD is confusing and a distinction without a difference. Either just bite the bullet and classify all…